معرفی
Michel Struys is a Professor in the Faculty of Medical Sciences at the University of Groningen, affiliated with the University Medical Center Groningen (UMCG). He holds leadership roles as Head of the Department of Anesthesiology and Chair of the cluster 'Acute, Peri-operative and Intensive Care Medicine'. Additionally, he serves as a Professor (5%) at Ghent University, Belgium, and holds editorial roles in journals like Anesthesiology and British Journal of Anaesthesia. His research focuses on pharmacokinetics, drug delivery optimization, and the environmental impact of anesthetics.
Research Interests: Dr. Struys specializes in anesthesiology, pharmacology, and neurosciences. His work spans drug metabolism modeling, sustainable anesthesia practices, and perioperative care. He actively investigates remimazolam pharmacology, opioid effects, and near-infrared spectroscopy for postoperative monitoring.
Publications: His recent work emphasizes environmental impacts of anesthetics (e.g., propofol vs. sevoflurane comparisons) and drug delivery systems. Key contributions include pharmacokinetic models for remimazolam and piperacillin/tazobactam, alongside studies on acute kidney injury prediction in pediatric cardiac surgery.
Grants & Industry Links: His research group received grants from companies like Masimo, Fresenius, and Baxter. He also holds royalties from intellectual property developed at Ghent University.
Labs & Teams: He leads the CAPE (Critical care, Anesthesiology, Peri-operative and Emergency medicine) research group at UMCG, focusing on translational and clinical anesthesia research.
